Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease

British Journal of Nutrition

Volumn 93, Issue 2, 2005, Pages 191-198

  Perlemoine, Caroline ^a   Macia, Frédéric ^a   Tison, François ^a   Coman, Isabelle ^a   Guehl, Dominique ^a   Burbaud, Pierre ^a   Cuny, Emmanuel ^b   Baillet, Laurence ^a   Gin, Henri ^a   Rigalleau, Vincent ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b Hôpital du Tripode   (France)

Author keywords

Diet induced thermogenesis; Parkinson's disease; Resting energy expenditure; Substrate oxidation; Weight change

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; GLUCOSE; LEVODOPA; ANTIPARKINSON AGENT; LIPID; PLASMA PROTEIN;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSKINESIA; ENERGY EXPENDITURE; ENERGY YIELD; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HUMAN; HYPERGLYCEMIA; LIPID OXIDATION; MALE; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; BLOOD; COMPARATIVE STUDY; DIET RESTRICTION; DRUG EFFECT; ELECTROSTIMULATION; ENERGY METABOLISM; METABOLISM; METHODOLOGY; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; WEIGHT GAIN;

ANTIPARKINSON AGENTS; BLOOD GLUCOSE; BLOOD PROTEINS; ELECTRIC STIMULATION; ENERGY INTAKE; ENERGY METABOLISM; FASTING; FEMALE; GLUCOSE; HUMANS; LEVODOPA; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; WEIGHT GAIN;

EID: 20144388756     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20041297     Document Type: Article

References (31)

1. Abbott RA, Cox M, Markus H & Tomkins A (1992) Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 46, 879-884.
2. Acheson KJ, Ravussin E, Wahren J & Jéquier E (1984) Thermic effect of glucose in man: obligatory and facultative thermogenesis. J Clin Invest 74, 1572-1580.
3. Atrens DM, Siviy SM, Holmes LJ, Solowij N & Jirasek M (1987) Hypothalamic modulation of thermogenesis and energy substrate utilization. Brain Res Bull 18, 303-308.
4. Beyer PL, Palarino MY, Michalek D, Busenbark K & Koller WC (1995) Weight change and body composition in patients with Parkinson's disease. J Am Diet Assoc 95, 979-983.
5. Bloesch D, Schutz Y, Breitenstein E, Jéquier E & Felber JP (1988) Thermogenic response to an oral glucose load in man: comparison between young and elderly subjects. J Am Coll Nutr 7, 471-483.
6. Broussolle E, Borson F, Gonzalez de Suso JM, Chayvialle JA, Beylot M & Chazot G (1991) Increase of energy expenditure in Parkinson's disease. Rev Neurol 147, 46-51.
7. Campbell AJ, Spears GFS, Brown JS, Busby WJ & Borrie MJ (1990) Anthropometric measurements as predictors of mortality in a community population aged 70 years and over. Age Ageing 19, 131-135.
8. Chen H, Zhang SM, Hernán MA, Willet WC & Ascherio A (2003) Weight loss in Parkinson's disease. Ann Neurol 53, 676-679.
9. Cuny E, Guehl D, Burbaud P, Gross C, Dousset V & Rougier A (2002) Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg 97, 591-597.
10. Durnin JVGA & Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32, 77-97.
11. Fahn S, Elton RL & members of the UPDRS Development Committee (1987) The unified Parkinson' s disease rating scale. In Recent Developments in Parkinson's Disease, vol. 2, pp. 153-163, 293-304 [S Fahn, CD Marsden, DB Calneand M Goldstein, editors]. New Jersey: Macmillan Healthcare Information.
12. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37, 287-301.
13. Jéquier E & Schutz Y (1988) Energy expenditure in obesity and diabetes. Diabetes/Metab Rev 4, 583-593.
14. Jéquier E & Tappy L (1999) Regulation of body weight in humans. Physiol Rev 79, 451-480.
15. Just H & Ostergaard K (2002) Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 17, 539-545.
16. Langsten JW & Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3, 129-133.
17. Levi S, Cox M, Lugon M, Hodkinson M & Tomkins A (1990) Increased energy expenditure in Parkinson's disease. Br Med J 301, 1256-1257.
18. Limousin P, Krack P, Pollak P, Benazzowz A, Ardorin C, Hoffmann D & Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339, 1105-1111.
19. Lopiano L, Rizzone M, Bergamasco B, Tavella A, Torre E, Perozzo P, Valentini MC & Lanotte M (2001) Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology 56, 552-554.
20. Markus HS, Cox M & Tomkins AM (1992) Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity. Clin Sci (Lond) 83, 199-204.
21. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P & Albanese A (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 53, 85-90.
22. Mueller PS & Horwitz D (1962) Plasma free fatty acid and blood glucose responses to analogues of norepinephrine in man. J Lipid Res 3, 251-255.
23. Parkinson J (1817) An Essay on the Shaking Palsy. London: Whittingham and Bowland.
24. Rigalleau V, Combe C, Blanchetier V, Aubertin J, Aparicio M & Gin H (1997) Low protein diet in uremia: effects on glucose metabolism and energy production rate. Kidney Int 51, 1222-1227.
25. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P & Albanese A (2002) Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 58, 1546-1550.
26. Sandyk R (1993) The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69, 125-130.
27. Toth MJ, Fishman PS & Poehlman ET (1997) Free-living daily energy expenditure in patients with Parkinson's disease. Neurology 48, 88-91.
28. Vardi J, Oberman Z, Rabey I, Streifler M, Ayalon D & Herzberg M (1976) Weight loss in patients treated long-term with levodopa. J Neurol Sci 30, 33-40.
29. Volkmann A, Allert N, Voges J, Weiss PH, Freund HJ & Sturm V (2001) Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56, 548-551.
30. Wermuth L, Stenager EN, Stenager E & Boldsen J (1995) Mortality in patients with Parkinson's disease. Acta Neurol Scand 92, 55-58.
31. Yapa RS, Playfer JR & Lye M (1989) Anthropometric and nutritional assessment of elderly patients with Parkinson's disease. J Clin Exp Gerontol 11, 155-164.